Добавлены профессиональными переводчиками и компаниями и на основе веб-страниц и открытых баз переводов.
proposal for a core-data for harpagophyti radix (devil’ s claw root) (*)
proposal for a core- data for lupuli flos (hop strobile) (*) proposal for a core- data for harpagophyti radix (devil’ s claw root) (*)
radix ginseng und daraus hergestellte extrakte sind als "fremde stoffe" im sinne des § 4 a (2) lmg zu beurteilen.
hadii gìnseng og ekstrakter, der »r fremstillet på grundlag heraf, må betragtes som "fremde stoffe" (fremmede stoffer) i overensstemmelse med § 4 a (2; i img.
note for guidance on non-clinical testing of herbal drug preparations with long-term marketing experience - guidance to facilitate mutual recognition and use of bibliographic data concept paper for a note for guidance on the investigation of biopharmaceutical characterisation and bioavailability/bioequivalence of herbal drugs/preparations position paper on the risk associated with the use of herbal products containing estragole position paper on the risk associated with the use of herbal products containing methyleugenol position paper on the risk associated with the use of herbal products containing á- and β -asarone position paper on the use of sassafras albidum as active substance or ingredient in herbal medicinal products concept paper on the levels of scientific evidence required for the authorisation of well-established use and traditional herbal medicinal products core-data on urticae radix core-data on lini semen core-data on rosmarini folium cum flore core-data on primulae radix
note for guidance on non- clinical testing of herbal drug preparations with long- term marketing experience - guidance to facilitate mutual recognition and use of bibliographic data concept paper for a note for guidance on the investigation of biopharmaceutical characterisation and bioavailability/ bioequivalence of herbal drugs/ preparations position paper on the risk associated with the use of herbal products containing estragole position paper on the risk associated with the use of herbal products containing methyleugenol position paper on the risk associated with the use of herbal products containing á - and β- asarone position paper on the use of sassafras albidum as active substance or ingredient in herbal medicinal products concept paper on the levels of scientific evidence required for the authorisation of well- established use and traditional herbal medicinal products core- data on urticae radix core- data on lini semen core- data on rosmarini folium cum flore core- data on primulae radix